"Tirzepatide for Obesity Treatment and Diabetes Prevention"
An ounce of prevention is worth a pound of cure, yes, however, this observation is truly remarkable (unprecedented), given that a drug, tirzepatide, which works by activating two types of receptors, GLP-1 and GIP (involved in insulin secretion and appetite regulation). This dual action helps lower blood sugar levels and promotes weight loss in individuals with type 2 diabetes.
"Improving health is the overarching goal of obesity treatment. Nearly 1 billion people are living with obesity,1 and of those, approximately two thirds have prediabetes.2 Characterized by insulin resistance and beta-cell dysfunction, prediabetes increases the risk of developing type 2 diabetes by as much as 70% over a lifetime.3"
"Three years of treatment with tirzepatide in persons with obesity and prediabetes resulted in substantial and sustained weight reduction and a markedly lower risk of progression to type 2 diabetes than that with placebo."